HONG KONG – The process whereby an extremely potent new antibody can neutralize infection by the Zika virus has been discovered by researchers at Duke-National University of Singapore Medical School (Duke-NUS), a key finding that may lead to development of the first effective Zika virus therapies. Read More

TOKYO – Public backlash against the proposal and internal agreement to cut the price of anticancer drug Opdivo (nivolumab) by half continues. Japan's Ministry of Health, Labour and Welfare (MHLW) promised to work on regular biennial drug price review and said the emergency review of Opdivo price was an anomaly. Read More

NEW DELHI – The Delhi High Court has set aside the Indian government's notification to ban 344 fixed-dose combination (FDC) medicines, which include some well-known branded cough syrups, saying the Indian government acted in a "haphazard manner." Read More

DOHA, Qatar – Tuberculosis, malaria, pandemic flu and an unknown disease are among the scariest infectious disease threats according to a group of experts gathered in Qatar for a global health summit. And, on a scale of one to 10, the state of readiness of the world to deal with such an outbreak was a resounding three. Read More

SHANGHAI – More than five years in the making, the FDA has granted Suzhou Alphamab Co. Ltd. clinical trial approval in the U.S. for KN035, an anti-PD-L1 single-domain agent discovered, developed and manufactured in China. Read More